Suppr超能文献

研究发现Cochrane系统评价中核心结局集的使用日益增加,并确定了促进因素和障碍。

Study found increasing use of core outcome sets in Cochrane systematic reviews and identified facilitators and barriers.

作者信息

Saldanha Ian J, Hughes Karen L, Dodd Susanna, Lasserson Toby, Kirkham Jamie J, Wu Yuhui, Lucas Samuel W, Williamson Paula R

机构信息

Department of Epidemiology, Center for Clinical Trials and Evidence Synthesis, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Department of Health Data Science, MRC-NIHR Trials Methodology Research Partnership, University of Liverpool, Liverpool, UK.

出版信息

J Clin Epidemiol. 2024 May;169:111277. doi: 10.1016/j.jclinepi.2024.111277. Epub 2024 Feb 29.

Abstract

OBJECTIVES

In 2019, only 7% of Cochrane systematic reviews (SRs) cited a core outcome set (COS) in relation to choosing outcomes, even though a relevant COS existed but was not mentioned (or cited) for a further 29% of SRs. Our objectives for the current work were to (1) examine the extent to which authors are currently considering COS to inform outcome choice in Cochrane protocols and completed SRs, and (2) understand author facilitators and barriers to using COS.

STUDY DESIGN AND SETTING

We examined all completed Cochrane SRs published in the last 3 months of 2022 and all Cochrane protocols published in 2022 for the extent to which they: (a) cited a COS, (b) searched for COS, (c) used outcomes from existing COS, and (d) reported outcome inconsistency among included studies and/or noted the need for COS. One investigator extracted information; a second extractor verified all information, discussing discrepancies to achieve consensus. We then conducted an online survey of authors of the included SRs to assess awareness of COS and identify facilitators and barriers to using COS to inform outcome choice.

RESULTS

Objective 1: We included 294 SRs of interventions (84 completed SRs and 210 published SR protocols), of which 13% cited specific COS and 5% did not cite but mentioned searching for COS. A median of 83% of core outcomes from cited COS (interquartile range [IQR] 57%-100%) were included in the corresponding SR. We identified a relevant COS for 39% of SRs that did not cite a COS. A median of 50% of core outcomes from noncited COS (IQR 35%-72%) were included in the corresponding SR. Objective 2: Authors of 236 (80%) of the 294 eligible SRs completed our survey. Seventy-seven percent of authors noted being aware of COS before the survey. Fifty-five percent of authors who did not cite COS but were aware of them reported searching for a COS. The most reported facilitators of using COS were author awareness of the existence of COS (59%), author positive perceptions of COS (52%), and recommendation in the Cochrane Handbook regarding COS use (48%). The most reported barriers related to matching of the scope of the COS and the SR: the COS target population was too narrow/broad relative to the SR population (29%) or the COS target intervention was too narrow/broad relative to the SR intervention (21%). Most authors (87%) mentioned that they would consider incorporating missing core outcomes in the SR/update.

CONCLUSION

Since 2019, there is increasing consideration and awareness of COS when choosing outcomes for Cochrane SRs of interventions, but uptake remains low and can be improved further. Use of COS in SRs is important to improve outcome standardization, reduce research waste, and improve evidence syntheses of the relevant effects of interventions across health research.

摘要

目的

2019年,仅有7%的Cochrane系统评价(SR)在选择结局时引用了核心结局集(COS),尽管存在相关的COS,但另有29%的SR未提及(或引用)。我们当前工作的目标是:(1)研究作者目前在Cochrane方案和已完成的SR中考虑COS以指导结局选择的程度;(2)了解作者使用COS的促进因素和障碍。

研究设计与设置

我们检查了2022年最后3个月发表的所有已完成的Cochrane SR以及2022年发表的所有Cochrane方案,以了解它们在以下方面的情况:(a)引用COS;(b)搜索COS;(c)使用现有COS中的结局;(d)报告纳入研究中的结局不一致情况和/或指出对COS的需求。一名研究人员提取信息;第二名提取人员核实所有信息,讨论差异以达成共识。然后,我们对纳入的SR的作者进行了在线调查,以评估对COS的认识,并确定使用COS指导结局选择的促进因素和障碍。

结果

目标1:我们纳入了294项干预措施的SR(84项已完成的SR和210项发表的SR方案),其中13%引用了特定的COS,5%未引用但提到搜索了COS。引用的COS中,核心结局的中位数为83%(四分位间距[IQR]为57%-100%)被纳入相应的SR。我们为39%未引用COS的SR确定了相关的COS。未引用的COS中,核心结局的中位数为50%(IQR为35%-72%)被纳入相应的SR。目标2:294项符合条件的SR中的236项(80%)的作者完成了我们的调查。77%的作者指出在调查前就知晓COS。55%未引用COS但知晓COS的作者报告称搜索过COS。报告最多的使用COS的促进因素是作者对COS存在的认识(59%)、作者对COS的积极看法(52%)以及Cochrane手册中关于使用COS的建议(48%)。报告最多的障碍与COS范围和SR的匹配有关:COS目标人群相对于SR人群过窄/过宽(29%)或COS目标干预相对于SR干预过窄/过宽(21%)。大多数作者(87%)提到他们会考虑在SR/更新中纳入缺失的核心结局。

结论

自2019年以来,在为Cochrane干预措施SR选择结局时,对COS的考虑和认识在增加,但采用率仍然较低,仍可进一步提高。在SR中使用COS对于改善结局标准化、减少研究浪费以及改善卫生研究中干预措施相关效应的证据综合非常重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验